299 related articles for article (PubMed ID: 33145669)
1. Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip.
Li Z; Li D; Guo Y; Wang Y; Su W
Biotechnol Lett; 2021 Feb; 43(2):383-392. PubMed ID: 33145669
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of drug combination for glioblastoma based on an intestine-liver metabolic model on microchip.
Jie M; Mao S; Liu H; He Z; Li HF; Lin JM
Analyst; 2017 Sep; 142(19):3629-3638. PubMed ID: 28853486
[TBL] [Abstract][Full Text] [Related]
3. Studies examining the synergy between Dihydrotanshinone and Temozolomide against MGMT+ glioblastoma cells in vitro: Predicting interactions with the blood-brain barrier.
Kumar V; Radin D; Leonardi D
Biomed Pharmacother; 2019 Jan; 109():386-390. PubMed ID: 30399573
[TBL] [Abstract][Full Text] [Related]
4. A pump-free tricellular blood-brain barrier on-a-chip model to understand barrier property and evaluate drug response.
Yu F; Kumar NDS; Foo LC; Ng SH; Hunziker W; Choudhury D
Biotechnol Bioeng; 2020 Apr; 117(4):1127-1136. PubMed ID: 31885078
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
6. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
8. An in vitro liver model on microfluidic device for analysis of capecitabine metabolite using mass spectrometer as detector.
Zhang J; Wu J; Li H; Chen Q; Lin JM
Biosens Bioelectron; 2015 Jun; 68():322-328. PubMed ID: 25599844
[TBL] [Abstract][Full Text] [Related]
9. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
[TBL] [Abstract][Full Text] [Related]
10. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
[TBL] [Abstract][Full Text] [Related]
11. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.
Agrawal U; Chashoo G; Sharma PR; Kumar A; Saxena AK; Vyas SP
Colloids Surf B Biointerfaces; 2015 Feb; 126():414-25. PubMed ID: 25601092
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
13. Assessment of hepatic metabolism-dependent nephrotoxicity on an organs-on-a-chip microdevice.
Li Z; Jiang L; Zhu Y; Su W; Xu C; Tao T; Shi Y; Qin J
Toxicol In Vitro; 2018 Feb; 46():1-8. PubMed ID: 28986290
[TBL] [Abstract][Full Text] [Related]
14. A Three-Dimensional Arrayed Microfluidic Blood-Brain Barrier Model With Integrated Electrical Sensor Array.
Jeong S; Kim S; Buonocore J; Park J; Welsh CJ; Li J; Han A
IEEE Trans Biomed Eng; 2018 Feb; 65(2):431-439. PubMed ID: 29346110
[TBL] [Abstract][Full Text] [Related]
15. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
16.
Peng B; Tong Z; Tong WY; Pasic PJ; Oddo A; Dai Y; Luo M; Frescene J; Welch NG; Easton CD; Thissen H; Voelcker NH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56753-56766. PubMed ID: 33226228
[TBL] [Abstract][Full Text] [Related]
17. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.
Xu L; Dan M; Shao A; Cheng X; Zhang C; Yokel RA; Takemura T; Hanagata N; Niwa M; Watanabe D
Int J Nanomedicine; 2015; 10():6105-18. PubMed ID: 26491287
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
20. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
